loadpatents
name:-0.032578945159912
name:-0.018231153488159
name:-0.0095570087432861
Mishra; Rama K. Patent Filings

Mishra; Rama K.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mishra; Rama K..The latest application filed is for "targeting pleckstrin-2 for treating cancer".

Company Profile
8.18.32
  • Mishra; Rama K. - Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy
Grant 11,453,640 - Shilatifard , et al. September 27, 2
2022-09-27
Targeting Pleckstrin-2 For Treating Cancer
App 20220001018 - Ji; Peng ;   et al.
2022-01-06
SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS
App 20210395206 - Schiltz; Gary E. ;   et al.
2021-12-23
Substituted heterocycles as c-MYC targeting agents
Grant 11,142,504 - Schiltz , et al. October 12, 2
2021-10-12
Cytochrome P450 Inhibitors And Uses Thereof
App 20210171515 - Panicker; Bijoy ;   et al.
2021-06-10
Small Molecules For Disrupting The Super Elongation Complex And Inhibiting Transcription Elongation For Cancer Therapy
App 20210094907 - Shilatifard; Ali ;   et al.
2021-04-01
Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)
Grant 10,851,082 - Schiltz , et al. December 1, 2
2020-12-01
Antifibrotic Compounds And Uses Thereof
App 20200069662 - PANICKER; Bijoy ;   et al.
2020-03-05
Cxcr4 Chemokine Receptor Modulators
App 20200039941 - Schiltz; Gary E. ;   et al.
2020-02-06
CXCR4 chemokine receptor modulators
Grant 10,435,375 - Schiltz , et al. O
2019-10-08
Cytochrome P450 inhibitors and uses thereof
Grant 10,414,760 - Panicker , et al. Sept
2019-09-17
Antifibrotic Compounds And Uses Thereof
App 20190125731 - PANICKER; Bijoy ;   et al.
2019-05-02
Substituted Heterocycles as c-MYC Targeting Agents
App 20190062281 - Schiltz; Gary E. ;   et al.
2019-02-28
Antifibrotic compounds and uses thereof
Grant 10,195,184 - Panicker , et al. Fe
2019-02-05
Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2)
Grant 10,093,668 - Schiltz , et al. October 9, 2
2018-10-09
Substituted Aromatic N-heterocyclic Compounds As Inhibitors Of Mitogen-activated Protein Kinase Interacting Kinase 1 (mnk1) And 2 (mnk2)
App 20180244654 - Schiltz; Gary E. ;   et al.
2018-08-30
Cxcr4 Chemokine Receptor Modulators
App 20180155295 - Schiltz; Gary E. ;   et al.
2018-06-07
Cytochrome P450 Inhibitors And Uses Thereof
App 20180148438 - Panicker; Bijoy ;   et al.
2018-05-31
Antifibrotic Compounds And Uses Thereof
App 20180008581 - PANICKER; Bijoy ;   et al.
2018-01-11
SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS
App 20170253581 - Schiltz; Gary E. ;   et al.
2017-09-07
Substituted Aromatic N-heterocyclic Compounds As Inhibitors Of Mitogen-activated Protein Kinase Interacting Kinase 1 (mnk1) And 2 (mnk2)
App 20170121326 - Schiltz; Gary E. ;   et al.
2017-05-04
Antifibrotic compounds and uses thereof
Grant 9,597,321 - Panicker , et al. March 21, 2
2017-03-21
Relaxin-like Compounds And Uses Thereof
App 20160152679 - Narayan; Prakash ;   et al.
2016-06-02
Relaxin-like Peptides And Uses Thereof
App 20160060322 - Narayan; Parkash ;   et al.
2016-03-03
Antifibrotic Compounds And Uses Thereof
App 20150306078 - PANICKER; Bijoy ;   et al.
2015-10-29
Cytochrome P450 Inhibitors And Uses Thereof
App 20150158853 - Panicker; Bijoy ;   et al.
2015-06-11
Antifibrotic compounds and uses thereof
Grant 9,040,555 - Panicker , et al. May 26, 2
2015-05-26
Antifibrotic Compounds And Uses Thereof
App 20140371234 - Panicker; Bijoy ;   et al.
2014-12-18
Cytochrome P450 inhibitors and uses thereof
Grant 8,865,752 - Panicker , et al. October 21, 2
2014-10-21
Cytochrome P450 Inhibitors And Uses Thereof
App 20140018401 - Panicker; Bijoy ;   et al.
2014-01-16
Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
Grant 8,598,359 - Sandanayaka , et al. December 3, 2
2013-12-03
Cytochrome P450 inhibitors and uses thereof
Grant 8,513,291 - Panicker , et al. August 20, 2
2013-08-20
Cytochrome P450 Inhibitors And Uses Thereof
App 20130102643 - Panicker; Bijoy ;   et al.
2013-04-25
Small Molecule Modulators Of Cytokine Activity
App 20100137285 - Zembower; David E. ;   et al.
2010-06-03
Small molecule modulators of cytokine activity
Grant 7,648,978 - Zembower , et al. January 19, 2
2010-01-19
Biaryl Substituted Heterocycle Inhibitors Of Lta4h For Treating Inflammation
App 20090163462 - SANDANAYAKA; Vincent ;   et al.
2009-06-25
Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation
Grant 7,402,684 - Sandanayaka , et al. July 22, 2
2008-07-22
Modulators of hepatocyte growth factor/c-Met activity
App 20080058312 - Zembower; David E. ;   et al.
2008-03-06
Modulators of hepatocyte growth factor/c-Met activity
App 20070213319 - Zembower; David E. ;   et al.
2007-09-13
Small molecule modulators of cytokine activity
App 20060116365 - Zembower; David E. ;   et al.
2006-06-01
Modulators of hepatocyte growth factor/c- Met activity
App 20060025406 - Zembower; David E. ;   et al.
2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed